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Abstract: The rampant spread of COVID-19 and the worldwide prevalence of infected cases demand
a rapid, simple, and cost-effective Point of Care Test (PoCT) for the accurate diagnosis of this pandemic.
The most common molecular tests approved by regulatory bodies across the world for COVID-19
diagnosis are based on Polymerase Chain Reaction (PCR). While PCR-based tests are highly sensitive,
specific, and remarkably reliable, they have many limitations ranging from the requirement of
sophisticated laboratories, need of skilled personnel, use of complex protocol, long wait times for
results, and an overall high cost per test. These limitations have inspired researchers to search for
alternative diagnostic methods that are fast, economical, and executable in low-resource laboratory
settings. The discovery of Loop-mediated isothermal Amplification (LAMP) has provided a reliable
substitute platform for the accurate detection of low copy number nucleic acids in the diagnosis
of several viral diseases, including epidemics like Severe Acute Respiratory Syndrome (SARS) and
Middle East Respiratory Syndrome (MERS). At present, a cocktail of LAMP assay reagents along
with reverse transcriptase enzyme (Reverse Transcription LAMP, RT-LAMP) can be a robust solution
for the rapid and cost-effective diagnosis for COVID-19, particularly in developing, and low-income
countries. In summary, the development of RT-LAMP based diagnostic tools in a paper/strip format or
the integration of this method into a microfluidic platform such as a Lab-on-a-chip may revolutionize
the concept of PoCT for COVID-19 diagnosis. This review discusses the principle, technology and past
research underpinning the success for using this method for diagnosing MERS and SARS, in addition
to ongoing research, and the prominent prospect of RT-LAMP in the context of COVID-19 diagnosis.
Keywords: point-of-care tests; COVID-19; coronavirus; SARS-CoV-2; LAMP; RT-LAMP; reverse
transcription loop-mediated isothermal amplification
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1. Introduction
The emergence of a novel coronavirus disease (COVID-19) in late 2019 and its subsequent evolution
into a pandemic created a severe global public health and economic concern. The pandemic has already
affected more than 8.5 million people and resulted in the death of about 450,000 people within six months
since the first reported case in Wuhan city, Peoples Republic of China [1,2]. The zoonotic infectious
agent, known as Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (SARS-CoV-2), is reportedly
transmitted among humans via respiratory droplets and aerosols generated from infected persons
while sneezing, talking, and/or coughing [3]. Based on the first report on the clinical examination of
patients, COVID-19 manifests with pneumonia and a set of symptoms which can include fever with or
without a cough, fatigue, myalgia, sputum production, headache, hemoptysis, and/or diarrhea [2].
Complications consist of respiratory distress, severe cardiac injury, RNAaemia, secondary infection,
and can even lead to death [2]. Thus, the pathological outcomes of COVID-19 were comparable with
that of SARS and Middle East Respiratory Syndrome (MERS) infections [4]. However, as more reports
come in, a major percentage of patients present to clinics with milder symptoms which can include
olfactory dysfunction [5] or a multisystem mild inflammation [6] that can initially go undetected, but
can become severe over time. In addition to patients being mildly symptomatic or often asymptomatic,
the aggressive community transmissibility sets COVID-19 apart from earlier episodes of respiratory
viral diseases, and contributes to its current pandemic proportions [7]. Lack of a cost-effective, reliable
testing method makes the scenario worse and urges researchers to develop and deploy a rapid, sensitive,
highly specific, and inexpensive Point of Care Test (PoCT)s in order to successfully identify the infected
persons early, provide the necessary medical support, and take mitigative measures to control the
spread of this disease [8].
Since, SARS-CoV-2 belongs to the same class as MERS and SARS viruses, and since their etiologies
mostly match, the approaches optimized for disease diagnosis during those epidemics can be considered
for COVID-19 diagnosis with modifications [9]. Along with X-Rays [10] and Computed tomography
(CT) imaging techniques [11], tests based on gene amplification by Polymerase Chain Reaction (PCR)
like quantitative reverse transcriptase PCR (qRT-PCR) and RT-PCR have been widely recognized
as standard confirmatory tests for coronavirus detection [12]. Despite the universal recognition of
PCR-based assays as a gold standard for molecular detection of viral diseases by government and
medical councils, these methods require highly skilled personnel and sophisticated equipment, which
makes them impractical in the setting of developing countries with limited resources. Moreover,
PCR-based methods require time-consuming and complicated protocols that limit their diagnostic
efficacy in an active pandemic situation with rapidly and exponentially increasing number of incidences,
specifically in populous regions of the world. Taken together, this necessitates substitution with an
equally reliable molecular detection method for diagnosing and controlling COVID-19.
One step loop-mediated isothermal amplification (LAMP) reaction is capable of detecting even a
few copies of target nucleic acid sequences under isothermal conditions (usually 60–65 ◦C) with the help
of specially designed primer sets. Due to its simplicity, it is gaining more popularity in the diagnosis of
various viral diseases [13–17]. Detection of RNA viruses requires an additional reverse transcriptase
enzyme and this method is then referred to as Reverse Transcriptase LAMP (RT-LAMP) [18]. Critical
features of RT-LAMP in comparison with RT-PCR are depicted in Figure 1. Unlike PCR, this technique
can be performed in a low-resource setting by merely heating the samples and reagents in a single
reaction tube. As illustrated, RT-LAMP has clear advantages over RT-PCR as a PoCT in a pandemic
scenario [19]. Indeed a simple visual inspection can even provide an idea about the outcome of the
LAMP reaction without involving any specialized equipment [18,20]. The cost of LAMP per test is also
considerably lower than other available molecular tests [21]. Thus, many researchers are focusing on
the optimization and modifications of RT-LAMP methodology to match the requirements of COVID-19
diagnosis in laboratories with limited resources in developing countries, where uncontrolled and
undetected spread of COVID-19 can result in an unpredictable outcome.
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Figure 1. Scheme showing the comparison of reverse transcription loop-mediated isothermal
amplification (RT-LAMP) with RT-PCR. Data is adapted from Dhama et al. [19].
The first clinically approved LAMP reagent was used for SARS diagnosis in Japan [22], which
indicates its potential as a PoCT for COVID-19. This review comprehensively discusses the reports on
the diagnostic application of LAMP-based assays in past viral epidemics and he c rr n COVI -19
andemic. It also provides notes on the basic prin iple, procedures, and possible improvements in the
existing LAMP-based a says and stresses o its advantages over other nucleic acid amplification-base
methods. Furthermore, this rticle rev als the potential of using a LAMP ass y as a simple and
easy-to-use platform for the ffec ive application as a PoCT tool for d agnosi g COVID-19.
2. Principle and Salient Features of the LAMP Method
The main components of LAMP reagents comprise of a set of salts, nucleotides, DNA polymerase,
(which catalyzes the synthesis of complementary strands with strand displacement activity), and four
to six primers including two loop primers (loop F an Loop B), forward and backward inner primers
(FIP and BIP, respectively), and two outer primers (F3 and B3) [23,24]. For detecting RNA viruses,
a heat-stable reverse transcriptase enzyme is also needed as an additional component [23]. A brief
schematic representation of the details of the molecular-level process of the RT-LAMP assay is shown
in Figure 2.
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Figure 2. Schematic representation displaying the process of the amplification for the RT-LAMP assay.
Initiall , the LAMP primers b nd to the c mplementary target cDNA sequences (in the case of RNA
viral detection), and dumbbell-shaped DNAs are produced. Then, during the cycling amplification
step, sever l copi s of such dumbbell DNAs are continuously produced. The products formed during
the cycling amplification step are used in the elongation phase to generate amplified DNA with
various sizes.
Development of a LAMP assay for the diagnosis of a specific disease starts with designing
specific LAMP primers using online tools such as PrimerExplorer and LAVA (LAMP Assay Versatile
Analysis) [25]. The primer sequences are represented as F3, F2, F1, B3, B2, and B1. Among these,
F3 and B3 are the forward outer and reverse outer primers, respectively. The F2/B2 sequences and
their complementary F1/B1 (F1c/B1c) sequences are referred to as FIP and BIP. Typically, four primer
sequences are enough to amplify a target nucleic acid [26,27], but, to enhance the specificity and efficacy
of the reaction, two additional loop primers (LoopF and LoopB) are incorporated in the LAMP reaction
mixture [14]. The loop primers identify the area between the F2/B2 and F1/B1 in the sequence [27].
In addition to the primers, the LAMP methods require Bst polymerase, deoxynucleotide triphosphates
(dNTPs), magnesium sulfate, betaine, and buffer solution for the enzyme [28]. The amplification
products, which have a stem-loop DNA structure, contain numerous inverted repeats of the objective
region and cauliflower-like structures with multiple loops (Figure 2). The LAMP assay can rapidly
(within an hour) amplify and produce a large number of DNA copies, usually 100 times higher than
conventional PCR, at 60–65 ◦C [29]. Moreover, the amplification of the target sequences, correlative to
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the initial quantity, can be assessed by a simple visual examination of the turbidity, which results from
a white precipitation of magnesium pyrophosphate as a by-product of the reaction [20,30–32].
To obtain a more robust result, an inexpensive turbidimeter can be employed to quantify the
turbidity at 650 nm in the reaction tube. The detection of LAMP amplicons can also be confirmed
with several simple techniques such as agarose gel electrophoresis [33] by measuring fluorescence
from the incorporated DNA intercalating agents such as SYBR Green I [34] or other modifications [35].
However, for the sake of rapidity, visual detection can be an immediate and straightforward option for
laboratories without specialized equipment in the context of COVID-19 diagnosis [28]. A colorimetric
visual inspection method has been developed where a suitable dye was dried in the caps of the reaction
tubes to detect the amplified nucleic acids [36]. At the end of the reaction, amplicons were mixed with
the dye and the color changes indicated the presence of a positive reaction.
3. LAMP for the Diagnosis of Viral Diseases
LAMP diagnostic methods have been extensively used for detecting both DNA and RNA viral
pathogens [37,38]. These assays have been developed and used for diagnosing several widespread
human pathogenic agents such as human immunodeficiency virus (HIV) [39], Japanese Encephalitis
virus [40], Chikungunya virus [16], human papillomavirus [41], Dengue virus [15,42], West Nile
virus [43], and Mumps virus [44]. Highly pathogenic avian influenza (HPAI) H5N1 virus [45,46], SARS
virus [47], and MERS virus [48]. As in the case of PCR tests, LAMP–based tests also start with the
collection of samples from the patient. For respiratory viral diseases like SARS, MERS, and COVID-19,
samples can be collected by a nasopharyngeal and/or oropharyngeal swab or sputum [49]. Notably,
in case of patients where the infection is already lodged deeper in the respiratory tract, a sputum
sample might present fewer chances of a false negative result. It also presents significantly lower risk
of exposure for healthcare workers, as sputum can be self-collected by the patient under contactless
supervision. A schematic representation of the standard operating procedure (SOP) for LAMP-based
viral pathogen detection is provided in Figure 3. In case of contagious viral diseases, samples should
be heat-inactivated before subsequent steps. Generally, adsorbent tubes are used to remove inhibitors
present in the samples, which may interfere with the reaction. The samples or extracted viral nucleic
acids are usually mixed with the LAMP reagents and heated at 60–65 ◦C for about 30 min to complete
the amplification.
In addition to detection of viral diseases [50], microbial infections have utilized LAMP-based
detection, successfully, and often directly from clinical samples without isolating RNA [18,51]. While
directly using patient samples, a single set of specific primers targeted toward the fusion-protein
gene could produce amplicons in two hours. Cross-validation by conventional PCR strengthened
the reliability of this system. Another remarkable advancement was the effective use of dry LAMP
reagents that simplified the storage and handling of samples without compromising on the sensitivity
or specificity [52]. Such modifications can majorly contribute toward the development of the RT-LAMP
as a suitable PoCT for COVID-19. Portable units of the RT-LAMP, which can deliver accurate results
within 15 min, eliminate the need for multiple equipment-based steps that can also have immense
potential during a pandemic [53].
All reports, so far, point toward the potential revolutionary role and benefits of modified RT-LAMP
over conventional PCR as PoCT in the current COVID-19 pandemic and the likes of it in the future.
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4. RT-LAMP for the Diagnosis of SARS
SARS coronavirus (SARS-CoV) is a zoonotic virus that reportedly appeared for the first time in
Guangdong province, China, in 2003, which was transmitted to humans from bats, and eventually
spread to 26 countries by infecting about 8000 people in the same year [54].
Notomi et al. first reported an effective RT-LAMP-based amplification and detection method
for the SARS virus, which could detect as low as 10 viral RNA copies/test within 45 min [55].
In two consecutive reports, the first one using patient serum samples [56], and the next one using
nasopharyngeal aspirates [57] of clinically diagnosed SARS patients, Poon et al. endorsed the use
of the RT-LAMP as an on-site detection method over conventional RT-PCR due to its simplicity and
considerably lower cost. In a different study, using throat and nasal swabs, and combinations, from
patients in the Vietnam SARS epidemic, the RT-LAMP assay reportedly showed a 100-fold higher
sensitivity with a detection limit of 0.01 PFU (plaque-forming units) in less than an hour [47].
Several simultaneous investigations successfully attempted to improve the efficacy and sensitivity
of SARS virus detection over a conventional nucleic acid amplification-based method and immunoassays
by designing directed primer sets [58–60], and also by simplifying the reaction readout [59,60]. Changes
in visual detections were brought about by employing calcein dye [59] or a multiplexed colorimetric
reaction [60]. Remarkably, these improvements reflected upon the ‘sample-to-answer’ time being
brought down to less than 30 min.
In light of these reports, RT-LAMP can be viewed as an accessible PoCT or near PoCT method for
clinical testing in developing countries.
5. RT-LAMP for the Diagnosis of MERS
The MERS coronavirus (MERS-CoV), which is a beta coronavirus linked to a severe form of
respiratory disease with a high fatality rate (~35%), was first reported in Saudi Arabia in 2012 [61] and
spread beyond the Middle East [62]. Like most of the other known coronaviruses, MERS-CoV was also
zoonotic in origin and was transmitted to humans from dromedary camels [63].
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The first report using primers targeting nucleocapsid nucleotide sequences of MERS coronavirus
implied that RT-LAMP should be chosen over RT-PCR for rapid diagnosis due to better sensitivity
(0.7 copies of viral RNA detection compared to 1.6 copies) in less time (30 min) [64]. Later, this same
group reported an improved visualization technique using quenching probes in place of the formerly
used fluorescence-based detection [65]. A subsequent study corroborated the sensitivity (0.02–0.2
PFU detected in supernatants of infected cells) factor and validated the addition of one-step strand
displacement probes (OSD) for real-time sequence-specific detection of LAMP amplicons. Further
improvement in sensitivity and deployability was brought about by using one-pot RT-LAMP, and six
targeted primers, which could detect as few as 0.4 copies of the virulent genome using a micro-chamber
device [66].
A more straightforward and hassle-free method was established by combining the RT-LAMP
assay with a vertical flow visualization strip (RT-LAMP-VF) [67]. After the amplification, the amplicons
labeled with biotin and fluorescein isothiocyanate (FITC), which were present in two loop primers. The
biotin-labeled amplicons could then bind to the colloidal gold particles, conjugated with streptavidin,
and form a complex that was detected by the anti-FITC antibody (coated on the test line of the strip) as
a visible colored line.
Although there is no clear evidence for the widespread use of the RT-LAMP method as a PoCT in
a clinical setting for the diagnosis of MERS, the results of the past studies suggest that the modified
RT-LAMP assays can be used as efficient PoCT for the fast diagnosis of this highly infectious disease.
6. RT-LAMP for the Diagnosis of COVID-19
According to the Center for Disease Control and Prevention (CDC) guidelines, swabs from the
nasopharynx swabs, anterior nares, and mid-turbinate (latter two for symptomatic patients) can be
used as samples for COVID-19 diagnosis in a healthcare setting. However, the idea of using the
RT-LAMP reaction for the rapid detection of COVID-19 started arguably with a report from El-Tholoth
et al. in early February 2020 [68]. Since this study was performed before COVID-19 assumed pandemic
proportions, they could not use actual clinical samples. Instead, they used a synthetic DNA sequence of
the viral agent, then called novel coronavirus (or nCoV), to test the feasibility of RT-LAMP application.
Later, simulated patient samples viz. human saliva, serum, oropharyngeal swabs, nasopharyngeal
swabs, and urine samples, spiked with COVID-19 nucleic acid sequences, were tested using the LAMP
method [69]. Subsequent studies focused on the approaches to improve the sensitivity and specificity
of the assay. One such study indicated that the primers designed for the RNA-dependent RNA
polymerase sequence (RdRp sequence) of the Open Reading Frame 1ab (Orf1ab) polyprotein region
of viral RNA showed higher amplification efficiency [70]. The RdRp primer information is included
in Figure 4A. The assay showed high specificity against clinical specimens positive for several other
known respiratory viruses (Figure 4B). Some other researchers reported the use of targeted primers for
varied structural protein encoding regions like the spike-protein encoding S gene, or nucleocapsid
encoding N gene, separately or in combination, with the common aim of achieving results with higher
sensitivity, specificity, and minimal cross-reactivity in a short amount of time [71–74]. Primers targeting
the Nsp3 gene in combination with those targeting N and S genes generated significantly satisfactory
results and registered the shortest threshold time for cDNA production [73]. To further improve the
efficacy of RT-LAMP reaction as a PoCT, researchers used several colorimetric detection methods
where color-changing reagents were incorporated in the reaction mixture. A master mix composed of
a pH-sensitive indicator dye (cresol red) was evaluated for the rapid RT-LAMP-based visual detection
of COVID-19 [70,75,76]. This dye changes its color from red to orange-yellow as an indication of a
positive reaction (Figure 4C,D) [77]. In positive samples, the pH of the LAMP reaction mixture tends to
decrease because of higher DNA polymerase activity. Such a colorimetric RT-LAMP method utilizing
phenol red (pH indicator), which changes color from pink to yellow at low pH, can also be used as a
simple detection method in resource limited settings [78,79]. Moreover, rapid visual detection of a
positive reaction can be done by using a LAMP master mix supplemented with SYTO®-9 (Thermo
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Fisher S34854, a double-stranded DNA or dsDNA binding agent), or leuco-crystal violet (that changes
from colorless to violet on contact with dsDNA) [36,80].
Recent investigations focus on simplifying the procedure even further by incorporating everything
in a ‘one-step’ or ‘single-tube’ assay using nanoparticle-based biosensors [81] or by including a magnetic
bead capture step during processing of dry swabs to maximize viral RNA yield [81,82]. Although
such advances are highly promising, further optimization studies are required to improve sensitivity
and specificity. Numerous and various clinical samples need to be tested as well to satisfactorily
demonstrate the consistent clinical applicability of these modified approaches.
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method for the detection of SARS-CoV-2. (A) Location of RdRp primer sequence in the SARS-CoV-2
genome. (B) Cross-reactivity test of the novel SARS-CoV-2 RT-LAMP assay to other common
respiratory viruses. Viral RNA isolated from a OVID-19 positive patient w s us d as a positive control
(PC). NTC, non-template control. (C) RT-LAMP based colorimetric visual detection of SARS-CoV-2 RNA
standards. (D) Clinical samples from positive (+) or negative (−) COVID-19 cases. NTC: non-template
control. (E) Schematic representation of the SARS-CoV-2 DETECTR method workflow such as RNA
extraction. The DETECTR method that involves the LAMP preamplification, and Cas12-based gene
detection, and visualization by a fluorescent reader or lateral flow strip (TwistDx). (F) LoD for DETECTR
assay showing the fluorescence values using SARS-CoV-2 DETECTR assay (n = 6) using SARS-CoV-2
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N2 gene in vitro-transcribed (IVT) RNA. Representative lateral flow results for the assay of samples
with 0 copies per µL and 10 copies per µL viral RNA. (G) Lateral flow strips showing SARS-CoV-2
DETECTR assay results after 3 min of flow. A–D are reproduced with permission from Lu et al. [70].
E–G are reproduced with permission from Broughton et al. [83].
Most recently, Broughton et al. successfully reconfigured a DNA Endonuclease Targeted CRISPR
Trans Reporter (DETECTR) platform using a visual lateral flow strip format to rapidly and accurately
detect SARS-CoV-2 [83]. A schematic representation of the mechanism is provided in Figure 4E. This
device used isothermal preamplification of primers based on protocols validated by government
regulatory bodies. The system was able to provide the results within 30 min (from sample collection to
result) with high sensitivity (10 copies of RNA per µL) (Figure 4F). To ensure the maximum specificity
of detection, they used a high-fidelity CRISPR detection enzyme and designed sets of Cas12 guide
RNAs (gRNAs) that can either differentiate SARS-CoV-2 or provide multi-coronavirus strain detection.
The lateral flow strip format was highly effective to detect even a very low concentration of viral RNA
per µL (Figure 4G).
In an effort to develop inexpensive apparatuses (that can be manufactured at large scale), an
interesting study reported the development of a 3D-printed incubation chamber for performing
RT-LAMP reactions and for successfully detecting SARS-CoV-2 in commercially available Eppendorf
PCR tubes [84]. Conceivably, along with essential research efforts from various academic and research
institutions across the world, public-private partnerships for bulk production of necessary equipment
and reagents can help in implementing RT-LAMP as a PoCT for the rapid diagnosis and mitigation of
the COVID-19 pandemic.
7. Challenges and Prospects
Recent advances in LAMP technology suggest that there has been considerable progress in detecting
target sequences with high specificity and sensitivity, which will help in the rapid diagnosis of a large
population of suspected patients in a pandemic like COVID-19. Although the method is well-established
with numerous recent modifications to match the disease-specific and pandemic-specific requirements,
some challenges remain. The main disadvantage of LAMP-based method is the complexity of primer
design [85] to achieve the specificity of a PCR test while providing the advantage of performing
the whole experiment at a fixed temperature. Another possible limitation of such methods is that it
can generate false-positive results due to the carry-over from previous experiments (due to its high
sensitivity), especially when upgraded into an automated platform [86]. Notably, RT-LAMP detection
by quenched fluorescent primers can overcome such limitations [87]. Several further modifications of
the LAMP method to match the requirements of the COVID-19 pandemic are at the optimization and
validation stages in various laboratories across the world. A schematic representation of such possible
modifications is provided in Figure 5.
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Figure 5. Sche atic representation of the future possible advances in RT-LA P based point-of-care
test (PoCT) for novel coronavirus disease (COVID-19). LAMP reagents can be loaded in a paper-based
system for easy use, which can be heated after sample loading to get quick results. Another advancement
will be the coating of the LAMP reagent on the walls of a reaction tube where a simple mixing of
the sample with the buffer and heating will give the results. Similarly, an RT-LAMP test-strip, like a
conventional pregnancy detection kit, can also be developed. The researchers will also explore the
possibility of developing an RT-LAMP master mix that can react at room temperature, which will fully
transform the current concept of RT-LAMP based diagnosis. Most advanced development will be a lab
on a chip (or LAMP on a chip) with advanced microfluidics, sensors, and computer integration, which
can also be connected with an electronic device like computer or mobile phone to analyze the results.
Although there is a challenge of keeping individual components in a non-reactive state, one of the
prospective advancements is using reaction tubes with dry master-mix coated on the inner walls or caps.
This can save time, which allows the lab technicians to omit adding different reagents individually to
the reaction tube. Use of dry reagents also overcomes the requirement of cold storage facilities and
temperature-controlled shipping [88,89]. In order to achieve fast result readouts, the LAMP technique
can be multiplexed with polymeric beads tagged with specific optical signatures for barcoding [90].
Barcoding is already used for research but implementing the same for COVID-19 diagnostic purposes
requires proper validation and scaling up. For easy digitalization of results and data management,
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computer integration of optical sensors for barcode scanning or use of nanomaterials that change
electrical or magnetic properties upon binding to target sequences can prove beneficial [91–93]. Another
report mentions analyzing the color change of gold nanoparticles in a salt solution on amplification of
the viral genomic DNA [94].
A paper-based LAMP system for COVID-19 diagnosis has already been proposed by Yang et
al. [95]. With some modifications, this can be transformed into a diagnostic tool [74,96,97] for use by
any home-quarantined person or an individual with limited access to healthcare facilities, who can
perform a self-test and share the results with healthcare professionals for remote analysis. Moreover,
a strip-based rapid and accurate test, like the reconfigured DETECTR platform from Mammoth
Biosciences, in combination with a glucometer-like readout machine, can completely revolutionize
the concept of pandemic monitoring with home-based diagnosis [83]. A caveat of widely deploying
LAMP-based diagnostic tools in home settings, however, is to ensure workability of the entire reaction
at room temperature, which is difficult, but achievable.
A recent study demonstrated the possibility to fully automate LAMP methods for the rapid and
effortless molecular diagnosis [98], which may pave a way to the automation of RT-LAMP based
COVID-19 diagnosis. In this system called “Simprova” (Developed by Eiken Chemical Co., Ltd.),
a central unit that controls the entire system, a pretreatment unit that isolates and purifies nucleic
acid from samples, and the LAMP component to detect and amplify nucleic acid sequences were all
integrated. Such systems (with inclusion of RT-enzyme) or microfluidic devices [90,99–101] can be
cost-effective, portable, and can prove extremely effective in generating fast results using minimal
samples and reagents. This is more likely when connected to an electronic device like computer or
smartphone for real-time transmission to a pandemic monitoring center [102].
Thus, despite the existing shortcomings, RT-LAMP based methods have tremendous potential as
a PoCT to meet the current diagnostic challenges of COVID-19.
8. Conclusions
As already reported for the effective diagnosis of several viruses, including coronaviruses causing
SARS and MERS, RT-LAMP has been widely investigated for its vast potential in diagnosing and
controlling the COVID-19 pandemic in developing countries. In addition to serving as a life-saving tool
for large populations residing in parts of the world without access to modern diagnostic facilities, it
would not be wrong to suggest that even developed countries struggling to control the rampant spread of
the disease can benefit immensely from implementing modified RT-LAMP-based PoCT or home-based
diagnostic tools. This method understandably has significant advantages over conventional RT-PCR in
a pandemic scenario like the present one.
Ideally, for easy and largescale deployment, the detection modules must be miniaturized and
integrated with the on-chip RT-LAMP system. In conclusion, the integration of the RT-LAMP method
with optical and nanomaterial-based system and/or advanced information technologies can help realize
a PoCT for the rapid, sensitive, specific, and cost-effective diagnosis of COVID-19 by minimally trained
individuals and with limited technical infrastructure in developing and developed countries alike.
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